CGON logo

CG Oncology, Inc. (CGON) Cash From Investing

Annual CFI:

-$300.76M-$179.57M(-148.17%)
December 31, 2024

Summary

  • As of today, CGON annual cash from investing is -$300.76 million, with the most recent change of -$179.57 million (-148.17%) on December 31, 2024.
  • During the last 3 years, CGON annual cash from investing has fallen by -$300.67 million (-309965.98%).
  • CGON annual cash from investing is now -309965.98% below its all-time high of -$97.00 thousand, reached on December 1, 2021.

Performance

1-Year Change

-148.17%

3-Year Change

-309965.98%

5-Year Change

-309965.98%

15-Year Change

-309965.98%

CGON Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

8.79%
CGON annual cash from investing is higher than 8.79% of companies in Healthcare sector

Range

All-Time High

-$97.00K
CGON annual cash from investing is currently >-9900.00% below its historical high of -$97.00 thousand

3-Year Low

-$300.76M
CGON annual cash from investing is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
CGON previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
CGON next annual earnings announcement has not yet been scheduled

OtherCGONcash flow metrics

Annual CFF

$628.28M
CGON annual cash from financing is $628.28 million

Annual CFO

-$78.71M
CGON annual cash from operations is -$78.71 million

Annual FCF

-$78.95M
CGON annual free cash flow is -$78.95 million

Annual CAPEX

$234.00K
CGON annual capital expenditures is $234.00 thousand

Quarterly CFI:

$1.41M+$188.18M(+100.75%)
June 30, 2025

Summary

  • As of today, CGON quarterly cash from investing is $1.41 million, with the most recent change of +$188.18 million (+100.75%) on June 30, 2025.
  • Over the past year, CGON quarterly cash from investing has increased by +$37.64 million (+103.88%).
  • CGON quarterly cash from investing is now -98.64% below its all-time high of $103.36 million, reached on June 30, 2023.

Performance

3-Month Change

+100.75%

1-Year Change

+103.88%

3-Year Change

-

5-Year Change

-

CGON Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

76.51%
CGON quarterly cash from investing is higher than 76.51% of companies in Healthcare sector

Range

All-Time High

$103.36M
CGON quarterly cash from investing is currently -98.64% below its historical high of $103.36 million

3-Year Low

-$307.44M
CGON quarterly cash from investing is currently +100.46% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2025
CGON previous earnings announcement was published on Jun 30, 2025

Next Quarterly Earnings Report Date

Nov 12, 2025
CGON next earnings announcement is scheduled for Nov 12, 2025

OtherCGONcash flow metrics

Quarterly CFF

-$296.00K
CGON quarterly cash from financing is -$296.00 thousand

Quarterly CFO

-$27.96M
CGON quarterly cash from operations is -$27.96 million

Quarterly FCF

-$27.97M
CGON quarterly free cash flow is -$27.97 million

Quarterly CAPEX

$14.00K
CGON quarterly capital expenditures is $14.00 thousand

TTM CFI:

-$142.45M+$37.64M(+20.90%)
June 30, 2025

Summary

  • As of today, CGON TTM cash from investing is -$142.45 million, with the most recent change of +$37.64 million (+20.90%) on June 30, 2025.
  • Over the past year, CGON TTM cash from investing has increased by +$185.69 million (+56.59%).
  • CGON TTM cash from investing is now -219.82% below its all-time high of $118.89 million, reached on December 31, 2023.

Performance

3-Month Change

+20.9%

1-Year Change

+56.59%

3-Year Change

-

5-Year Change

-

CGON TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

13.23%
CGON TTM cash from investing is higher than 13.23% of companies in Healthcare sector

Range

All-Time High

$118.89M
CGON TTM cash from investing is currently -219.82% below its historical high of $118.89 million

3-Year Low

-$328.14M
CGON TTM cash from investing is currently +56.59% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2025
CGON previous earnings announcement was published on Jun 30, 2025

Next Quarterly Earnings Report Date

Nov 12, 2025
CGON next earnings announcement is scheduled for Nov 12, 2025

OtherCGONcash flow metrics

TTM CFF

$225.74M
CGON TTM cash from financing is $225.74 million

TTM CFO

-$93.82M
CGON TTM cash from operations is -$93.82 million

TTM FCF

-$94.06M
CGON TTM free cash flow is -$94.06 million

TTM CAPEX

$240.00K
CGON TTM capital expenditures is $240.00 thousand

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

CGON Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-148.2%+103.9%+56.6%
3Y3 Years-10000.0%--
5Y5 Years-10000.0%--

CGON Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year>-9999.0%at low-98.6%+100.5%-219.8%+56.6%
5Y5-Year>-9999.0%at low-98.6%+100.5%-219.8%+56.6%
All-TimeAll-Time>-9999.0%at low-98.6%+100.5%-219.8%+56.6%

CGON Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2025
-
$1.41M(+100.8%)
-$142.45M(+20.9%)
Mar 2025
-
-$186.77M(-1812.7%)
-$180.09M(+40.1%)
Dec 2024
-$300.76M
$10.90M(-65.9%)
-$300.76M(-1.6%)
Sep 2024
-
$32.01M(+188.3%)
-$296.13M(+9.8%)
Jun 2024
-
-$36.23M(+88.2%)
-$328.14M(-74.0%)
DateAnnualQuarterlyTTM
Mar 2024
-
-$307.44M(-2079.2%)
-$188.55M(-258.6%)
Dec 2023
-$121.19M(-119.0%)
$15.53M(-85.0%)
$118.89M(+15.0%)
Jun 2023
-
$103.36M
$103.36M
Dec 2022
-$55.35M(>-9900.0%)
-
-
Dec 2021
-$97.00K
-
-

FAQ

  • What is CG Oncology, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for CG Oncology, Inc.?
  • What is CG Oncology, Inc. annual cash from investing year-on-year change?
  • What is CG Oncology, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for CG Oncology, Inc.?
  • What is CG Oncology, Inc. quarterly cash from investing year-on-year change?
  • What is CG Oncology, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for CG Oncology, Inc.?
  • What is CG Oncology, Inc. TTM cash from investing year-on-year change?

What is CG Oncology, Inc. annual cash from investing?

The current annual cash from investing of CGON is -$300.76M

What is the all-time high annual cash from investing for CG Oncology, Inc.?

CG Oncology, Inc. all-time high annual cash from investing is -$97.00K

What is CG Oncology, Inc. annual cash from investing year-on-year change?

Over the past year, CGON annual cash from investing has changed by -$179.57M (-148.17%)

What is CG Oncology, Inc. quarterly cash from investing?

The current quarterly cash from investing of CGON is $1.41M

What is the all-time high quarterly cash from investing for CG Oncology, Inc.?

CG Oncology, Inc. all-time high quarterly cash from investing is $103.36M

What is CG Oncology, Inc. quarterly cash from investing year-on-year change?

Over the past year, CGON quarterly cash from investing has changed by +$37.64M (+103.88%)

What is CG Oncology, Inc. TTM cash from investing?

The current TTM cash from investing of CGON is -$142.45M

What is the all-time high TTM cash from investing for CG Oncology, Inc.?

CG Oncology, Inc. all-time high TTM cash from investing is $118.89M

What is CG Oncology, Inc. TTM cash from investing year-on-year change?

Over the past year, CGON TTM cash from investing has changed by +$185.69M (+56.59%)
On this page